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Abstract
Background: The mechanisms and kinetics of hepatic growth have continuously
been investigated. This study concerns liver regeneration in animal and patients who
underwent partial hepatectomy evaluated by the hepatic extraction fraction (HEF)
calculated through radioisotopic methods.
Methods: Thirty normal Wistar rats were submitted to an 85% hepatectomy, and 95
patients with primary and secondary liver tumours were included. In animal study, the
liver regeneration kinetics was assessed by HEF using 99mTc-mebrofenin, the ratio
liver/bodyweight and by using bromodeoxyuridine deoxyribonucleic acid incorpora-
tion. In patient study, the liver regeneration was evaluated by calculation of HEF
before surgery, 5 and 30 days after hepatectomy.
Results: In animal, we verified a positive correlation between HEF kinetics and
liver/bodyweight ratio or hepatocyte proliferation evaluated by bromodeoxyuridine
deoxyribonucleic acid staining after 85% hepatectomy. In the clinical arm, no statis-
tical differences of the HEF before hepatectomy, 5 and 30 days after hepatectomy,
were observed.
Conclusions: Our results support the view that human liver regeneration commences
early, is fast, non-anatomical and functionally complete 5 days after hepatectomy. The
fast functional liver regeneration may have a high clinical impact particularly con-
cerning the post-operative oncological therapeutic approaches.
Introduction
Liver regeneration is defined as an orchestrated response induced by
specific external stimuli, leading to sequential changes in gene
expression, growth factors production, as well as morphological
structure (anatomy).1–3 Liver regeneration occurs through the prolif-
eration of all existing mature cellular populations composing the
intact organ. These include hepatocytes, biliary epithelial cells,
fenestrated endothelial cells with large cytoplasmic gaps that allow
maximal contact between circulating blood and hepatocytes,
Kupffer cells, oval cells, liver precursor cells, and Ito cells. These
cells synthesize connective tissue proteins and secrete several
growth factors, such as hepatocyte growth factor (HGF), epidermal
growth factor receptor ligands, epidermal growth factor, transform-
ing growth factor, alpha tumour necrosis factor and acidic fibroblast
growth factor. Besides this cellular intervention, humoral involving
interleukin 6, norepinephrine, insulin and bile acids are also
important.4–8
The mechanisms and kinetics of hepatic growth have continu-
ously been investigated by using either primary hepatocyte cell
cultures or partially hepatectomized animals, or by evaluating liver
volumes in recipient or donor patients after living donor transplan-
tation, as well as in patients following liver resections.9–13
As we know, liver resection remains the treatment of choice in a
number of primary and secondary liver tumours, and hepatectomy is
currently considered the standard of care and remains the only
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potential curative therapy for liver metastases of colorectal cancer.
Complete surgical resection of isolated or multiple hepatic
metastases has been associated with a 26–51% 5-year survival,
which confers a clear survival advantage over 0–5% survival in
patients who do not undergo liver resection.1–3 Similarly, liver resec-
tion can be considered the principal therapy for a specific group of
patients with hepatocellular carcinoma. Although liver transplanta-
tion is accepted as the best curative option for carefully selected
patients with hepatocellular carcinoma, this treatment cannot always
be offered due to either patients’ advanced age or scarcity of liver
donors, and as a result, even in this group, hepatic resection contin-
ues to be the treatment of choice for the majority of patients (yield-
ing 5-year survival rates as high as 60% in some series).4–6
Currently, nuclear medicine methodologies are able to give
dynamic functional information, with the possibility of lesion char-
acterization and also cell function. In this context, the 99mTc-
mebrofenin, a derivative of iminodiacetic acid labelled with 99mTc,
is transported into the hepatocyte by a high-capacity carrier-
mediated anionic clearance mechanism, organic anion transporter
polypeptide. After the uptake, acid imunodiacetic derivative is trans-
ported into the bile canaliculi by active membrane transport. These
compounds will have the same hepatocyte uptake, transport and
excretion pathways as bilirubin. Using 99mTc-mebrofenin, a deriva-
tive of imunodiacetic acid labelled with 99mTc is possible to evalu-
ate the hepatic extraction fraction (HEF) after intravenous injection.
The presence of radiotracer in the excreted biliary fluid represents
good hepatocyte function, that is tracer extraction and excretion.14–16
Changes in hepatocyte function modify the tracer cellular manage-
ment, reflecting the dynamic process referred to. Therefore, nuclear
imaging, which also provides information on biliary kinetic, is a
good investigating alternative for the hepatocellular function.
Based on this, we conducted a combined experimental and clini-
cal study to evaluate the liver regeneration using quantification of
HEF after partial hepatectomy.
Methods
Animal study
Thirty male Wistar rats of 2 months of age were used for the experi-
mental research. The animals were fed a laboratory diet with water
and food ad libitum until surgery. They were kept under constant
environment conditions with 12-h light–dark cycle. All the proce-
dures were performed in accordance with the national and interna-
tional animal care laws, and were approved by the local animal
ethics committee.
The induction of liver regeneration by partial hepatectomy
depends on the reduction of functional liver mass. In the rats, the
liver mass makes up circa 4% of the bodyweight, the individual liver
lobes constant proportions and each having a long vascular hilum
with segmental portal vein, hepatic artery and bile duct.13 The animal
model adopted was a major hepatectomy (partial hepatectomy of
85%), which was already described by Cantré et al., referred this
hepatectomy as an excellent model of liver regeneration, like those
who reported 70% hepatectomy in rat models.4,9
All the animals were anaesthetized with methoxyflurane and sub-
mitted to the major hepatectomy. Briefly, the abdomen was entered
through a midline incision, and the liver was freed from its liga-
ments. The left lateral lobe, median lobe and right superior lobe were
then resected by placing 3/0 suture ties most proximally to their
origin (left lateral and median lobes), or at short distance from their
origin (right superior lobe), guaranteeing adequate blood flow to
neighbouring residual lobe.9 Care was taken to avoid disruption of
the hilar structures, including portal vein, hepatic artery and biliary
tract. No animal was excluded due to mortality or morbidity. After
surgery, the animals were divided into five subgroups according to
the time they were sacrificed post hepatectomy: 12 h (six animals),
1 day (six animals), 2 days (six animals), 3 days (seven animals) and
5 days (five animals).
Liver regeneration study in animal
After sacrificing them, the remnant livers were procured and used to
evaluate liver regeneration kinetics through DNA incorporation of
5-bromo-2′-deoxyuridine (BrdU), and the ratio of liver and
bodyweight. In order to evaluate HEF, the animals were studied 5
days before surgery and 1 h before the sacrifice through an injection
of 99mTc-mebrofenin in a tail vein.
Overall liver regeneration was evaluated only on the animal
models. This information was obtained by two different approaches:
first, by weighting the animals and the remaining livers after the
hepatectomy and the calculation of liver to bodyweight ratio (LW/
AW) after euthanasia; and second, by analysing the DNA synthesis
using BrdU incorporation as described.12 Briefly, BrdU (Roche) was
dissolved in phosphate-buffered saline and injected (2 h before sac-
rificing the animals) in a concentration of 0.1 mg/g of the animal
bodyweight. Samples were collected and fixed in 10% tamponated
formaldehyde in order to be evaluated by fluorescence microscopy
to count the number of visualized nucleoli. For this analysis, five
independent optical fields were studied.
Patient study
Ninety-five patients were enrolled in this study from January 2007 to
May 2009. The mean age was 63.2  11.3 years (range: 32–83); 63
were men and 32 women. Sixty-nine patients had colorectal
liver metastases, sixteen had hepatocellular carcinoma, two had
cholangiocarcinoma, two had liver metastases from gastric cancer,
two had hepatic hemangioma and four patients had other tumours.
Ten patients were cirrhotic, diagnosed by radiological and histologi-
cal investigations.
The selection of patients for surgery was based on liver functional
status, radiological evidence of tumour resectability using computer
tomography (CT) or magnetic resonance, study of hepatic volumetry
by CT, absence of major contraindications precluding surgery, and in
the cases of hepatocellular carcinoma patients had to be outside the
Milan criteria17 and classified as Child–Pugh score grade A.18
Thirty-five patients (37%) underwent major hepatic resection
(resection of three or more liver segments) (MAHR): right extended
hepatectomy (n = 9), right hepatectomy (n = 11), central
hepatectomy (n = 2), extended left hepatectomy (n = 1),
left hepatectomy (n = 7) and trisegmentectomy (n = 5).
The remaining 60 patients (63%) underwent minor hepatic resec-
tion (MIHR): bisegmentectomy (n = 22), left lobectomy (n = 8),
segmentectomy (n = 25) and subsegmentectomy (n = 5).
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There was no immediate or 3-month post-operative mortality.
Post-operative morbidity was 5.2% (n = 5), which included wound
infection in two patients, respiratory complications in two patients
and bleeding peptic ulcer in one patient (treated conservatively).
The preoperative evaluation was done by standard liver bio-
chemistry (plasma levels of prothrombin, albumin, alanine
aminotransferase, aspartate aminotransferase, alkaline phosphatase,
gamma-glutamyl transpeptidase, total and direct/indirect bilirubin,
and lactic acid dehydrogenase) and Child–Pugh score.
All patients had HEF evaluated by radioisotopic methods with
intravenous injection at antecubital vein of 99mTc-mebrofenin, after
fasting for at least 6 h, before surgery (T0), 5 days after surgery (T5)
and 1 month after surgery (T30). The HEF was evaluated 5 days
after surgery because of convenience to patient.
Data analysis was performed considering major and minor
hepatectomy patients globally and separately.
The study protocol was approved by the ethics committee of
Coimbra University Hospital and Coimbra Faculty of Medicine. All
patients were informed about the study and signed an informed
consent.
Calculation of HEF
For HEF calculation, an iminodiacetic acid derivative, the 3-bromo-
2,4,6-trimethylphenylcarbamoilmethyl 1-iminodiacetic acid labelled
with technetium-99 m (99mTc-mebofrenin) was used. The labelling
procedure was performed by adding 1110 MBq of 99mTc freshly
eluted to a mebrofenin kit (GE-Amersham Health, Eindhoven, The
Netherlands). For the patients studied, 185 MBq was administrated,
and for the animals studies the administered dose was 37 MBq.
Related to dosimetry, the target organ that has the highest estimated
absorbed dose is the large bowel (9.2 E-02 mGy/MBq), according to
the Medical Internal Radiation Dose Committee guidelines.15,19
Data acquisition for experimental and clinical groups was per-
formed by a single detector gamma camera (GE Maxicamera 400
AC, Milwaukee, WI, USA) coupled with a low-energy, high-
resolution, parallel-hole collimator, controlled by a genieACQ com-
puter (GE, Milwaukee, WI, USA). Data were dynamically collected
after the bolus injection of 99mTc-mebrofenin for 128 ¥ 128 ¥ 16
matrix, every second during the first minute, followed by 59 frames
of 60 s each without zoom. After the dynamic acquisition, two 256
¥ 256 static images, anterior and posterior, were performed with an
individual duration of 67 s for decay correction.
All patients were positioned supine with the upper abdomen and
cardiac area included in the gamma camera field of view. For the
animals, the position was ventral decubitus directly over the colli-
mator, with the whole body in the gamma camera field of view.
Energy discrimination was centred on 140 keV with a 20% energy
window. After acquisition, the data were transferred to a work
station, eNTEGRA, for processing.
On the dynamic sequence of images, regions of interest (ROIs)
were flagged over the cardiac region and right hepatic lobe, avoiding
the gall bladder and main intrahepatic biliary ducts of patients. For
the animals studied, the entire liver remnant is included as they do
not have gall bladder. Time-activity curves were generated from
these ROIs, and the HEF was calculated through deconvolution
analysis of the first pass curve. This measurement also gives values
of the T1/2 (time needed to reduced liver activity to half, assuming
that the activity was instantaneously injected in the hepatic artery or
portal vein as a Dirac delta function) and Tmax (time of maximum
liver activity).
In the experimental arm involving animal subjects, normal HEF,
the T1/2 and Tmax values were of 98 5%, 20.9 14.6 min and 18
 4.6 min, respectively. Normal HEF values were of 99 0.4%, the
T1/2 values were 39 19 min and Tmax values were 15 6 min for
the patients.15
This technical approach was used in both, experimental and clini-
cal studies, to evaluate liver regeneration after hepatectomy, as
described before in animal studies.19–21
Statistical analysis
Continuous data were presented as mean and standard deviation.
Repeated measures analyses of variance were obtained by general-
ized linear models within effects (time) and one factor (hepatectomy)
on variables HEF (%), Tmax (min) and T1/2 (min) in all patients. P
values of0.05 were considered statistically significant.
For the correlation studies between HEF and BrdU incorporation
or LW/AW ratio after the partial hepatectomy, Pearson correlation
was applied and evaluated at 5% significant level.
Results
Animal studies
Correlation between post-operative HEF, T1/2, Tmax and
liver/bodyweight ratio
We verified a positive correlation between HEF kinetics and LW/AW
ratio after the hepatectomy, and a negative correlation between T1/2
or Tmax and LW/AW ratio after hepatectomy (Fig. 1a–c).
Correlation between post-operative HEF, T1/2, Tmax and
BrdU incorporation
A positive correlation between hepatocyte proliferation evaluated by
BrdU staining and HEF after hepatectomy was obtained. Similarly,
we observed a negative correlation between hepatocyte proliferation
and T1/2 or Tmax after surgery (Fig. 2a–d).
Patient studies
Correlation between pre- and post-operative HEF,
T1/2 and Tmax
Overall patient population. The mean HEF values in our series
were 97  10% for T0, 98  8% for T5 and 99  4% for T30 (P =
0.694). The mean Tmax values were 16 8 min for T0, 14 6 min
for T5 and 14  5 min for T30 (P = 0.073). The mean T1/2 values
were 36 22 min for T0, 86 105 min for T5 and 40 19 min for
T30 (P = 0.0001).
Subgroup of patients treated by major resection. For the 35 patients
who underwent MAHR, the HEF values were 97  5% (T0), 96 
13% (T5) and 99  2% (T30) (0.472); the mean Tmax values were
17  7 min for T0, 14  6 min for T5 and 15  5 min for T30
(0.073); and the mean T1/2 values were 27  26 min for T0, 89 
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74 min for T5 and 42  9 min for T30 (P = 0.001). There are
significant differences only for the values of T1/2 in T5 when com-
pared with T0 (P = 0.035) (Fig. 3a,b).
Subgroup of patients treated by minor resections. For the 60
patients who underwent MIHR, the HEF values were 97  11%
(T0), 99 2% (T5) and 99 5% (T30) (P = 0.879); the mean Tmax
values were 15  9 min for T0, 14  6 min for T5 and 14  6 min
for T30 (P = 0.098); and the mean T1/2 values were 39 19 min for
T0, 85  122 min for T5 and 39  22 min for T30 (P = 0.001).
There are significant differences only for the values of T1/2 in T5
when compared with T0 (P = 0.04) (Fig. 3a,c).
Discussion
During the last two decades, there have been major advances in the
understanding of the mechanisms of liver regeneration. This knowl-
edge, obtained from laboratory research using animals, alongside
with the use of data from solid organ transplantation in human, has
been applied in different experimental studies as well as certain
clinical situations.3–6 The research conducted so far has resulted in
the identification of a number of factors, such as HGF, transforming
growth factor-a, and heparin-binding epidermal growth factor-
like.1,3,4,6 Indeed, these factors play a very important role in enhanc-
ing and accelerating liver regeneration after liver resection or
transplantation, and could positively influence livers affected by
small-for-size syndrome or in injured livers secondary to trauma.
The induction of liver regeneration by partial hepatectomy
depends on the reduction of functional liver mass. The model of 2/3
hepatectomy in the rat devised many years ago by Higgins and
Anderson has found broad acceptance.13 Therefore, the increment of
the portion of liver resected increases the stimulus to liver regenera-
tion, so this is the reason why a hepatectomy of 85% was used.
Increasing the proportion of liver volume resected would increase
the stimulus to liver regeneration, and this was the rationale why
a hepatectomy involving up to 85% of liver parenchyma was
performed in our experimental arm. On the other hand, 85%
hepatectomy may mimic the changes of hepatic perfusion (e.g.
portal hyperperfusion) associated with reduced-size livers that can
be a source of complications as the small-for-size syndrome.9 This
is characterized by severe liver dysfunction or even liver failure in
the first post-operative week, and is consequently associated with
high mortality rate.9
Our experimental results show that immediately after
hepatectomy in the rat, the liver function decreases, with the lowest
values being at 24 h. After this time, the liver function recovers and
returns to normal. These results suggest a correlation between liver
function evaluated by 99mTc-mebrofenin and liver regeneration
evaluated with BrdU staining and LW/AW ratio quantification. Our
results are in line with the results published by others where no
significant differences were found between 99mTc-mebrofenin
uptake and conventional liver volume on days 3, 5 and 7 after 70%
hepatectomy was performed in same animal model.19,21 Also, in this
study, the authors demonstrated a good correlation between the
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Fig. 1. Correlation between post-operative hepatic extraction fraction (HEF), T1/2, Tmax and rat liver/bodyweight. (a) Positive correlation between HEF
kinetics and liver/bodyweight ratio after the 85% partial hepatectomy. (b) Negative correlation between T1/2 and liver/bodyweight ratio (LW/AW) after 85%
hepatectomy. (c) Negative correlation between Tmax and liver/bodyweight ratio (LW/AW) after 85% hepatectomy. (d) 99mTc-mebrofenin scintigraphic static
image in animal models before and 24 h after 85% partial hepatectomy.
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results of scintigraphic study with 99mTc-mebrofenin and the evalu-
ation of hepatocellular proliferation by immunohistochemistry using
monoclonal anti-Ki67, which is a marker of cell proliferation.22
Moreover, the authors also found that the 99mTc-mebrofenin uptake
was the most sensitive of all functional methods to evaluate hepatic
function during liver regeneration in standardized rat model.21
However, despite attempts, the obtained experimental data have
not been much applied or used in clinical practice (new treatment
strategies), and it was this motive that led us to conduct this
clinical research. The two questions we addressed in this study are
the following: First, do the same features of liver regenerations
observed in animals apply to the regeneration of the human
livers? Second, can our results be applied in our daily clinical
practice?
Concerning the above, our study demonstrated a surprising capac-
ity of human liver cells to regenerate, resulting in an early liver
regeneration. This regeneration occurs early enough to normalize
hepatic function (within 5 days after minor or major liver resection).
Nevertheless, hepatic depuration needs more time in the earlier
post-operative period (T5), which improves later reaching almost
normal values at T30. The delay on T1/2 can be explained by
the non-anatomic liver regeneration associated with the latter
cholangiocyte regeneration compared with the hepatocyte regenera-
tion verified in animal models of liver regeneration.5 In fact, the
latter cholangiocyte regeneration can be the cause of the longer T1/2,
despite the fact that the hepatocyte regeneration is already done.
Liver regeneration is difficult to study in humans, and despite exten-
sive research on the mechanisms responsible for the complex recov-
ery of hepatocellular volume and function that occur during liver
regeneration, they are not completely understood.
CT volumetry is considered the gold standard method to evaluate
liver volumetry. However, performing a CT volumetry study 24 h or
48 h after surgery is not easy considering patient’s condition after
complex liver surgery. Volumetric tests (e.g. CT volumetry),
however, has some limitations because it evaluates the volume but
does not distinguish functional from non-functional hepatic
‘volume’. Moreover, CT liver volume is an indirect measurement of
hepatic function because the method assumes a homogeneous dis-
tribution function, a reality that is not valid particularly in patients
with cirrhosis.20–22 Additionally, there is a poor correlation between
the volumetric regeneration and functional regeneration, particularly
during the first days after hepatectomy, and in our study it was
essential to use functional evaluation tests to assess the recovery
process of liver.20,22
The most frequently used test for evaluating preoperative liver
function is the indocyanine green (ICG) clearance test, which has
been shown to be a better indicator of liver function than the Child–
Pugh classification. ICG is a tricarbocyanine dye, exclusively
removed by the hepatocytes and excreted into the bile. Alternatively,
99mTc labelled iminodiacetic acid analogues, transported in blood
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Fig. 2. Correlation between post-operative hepatic extraction fraction (HEF), T1/2, Tmax calculation after 99mTc-mebofrenin administration and
bromodeoxyuridine deoxyribonucleic acid (BrdU) incorporation after rat 85% hepatectomy. (a) Positive correlation between hepatocyte proliferation
evaluated by BrdU staining and HEF after rat 85% hepatectomy. (b) Negative correlation between hepatocyte proliferation evaluated by BrdU staining and
T1/2 after rat 85% partial hepatectomy. (c) Negative correlation between hepatocyte proliferation evaluated by BrdU staining and Tmax after rat 85% partial
hepatectomy. (d) Hepatocyte proliferation evaluated by BrdU staining 24 h after rat 85% hepatectomy.
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by binding to albumin in the same manner as ICG, can be used for
hepatobiliary scintigraphy in the assessment of liver function. Both
ICG and 99mTc-mebrofenin are excreted in bile by the hepatocytes
by the ATP-dependent export pump multidrug resistance-associated
protein 2, without undergoing biotransformation during their transit
through the hepatocyte. Therefore, these agents are well suited for
the study of hepatic transport. In fact, 99mTc-mebrofenin uptake rate
assessed by scintigraphy is a valid method for determining liver
function, and correlates well with ICG clearance.23 On the other
hand, a correlation between liver function evaluated by ICG clear-
ance and hepatic parenchymal cell volume was also demonstrated.24
During the regeneration process of the liver, a strong correlation
between conventional liver volume and liver functional volume was
demonstrated.1–9,20 As liver regeneration is associated with liver
volume and/or liver weight increase, what we observed with the
proposed study is that hepatocellular function recovery occurs
before the liver regeneration process. Our results coming from
animal studies by analysing DNA synthesis using BrdU incorpora-
tion and the liver/bodyweight ratio also support the same conclusion.
Additionally, these results correlate with those observed in human
patients, showing that the human liver regeneration is fast, non-
anatomic and certainly complex.
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Fig. 3. Study of dynamic human liver regeneration. (a) Hepatic extraction fraction (HEF), Tmax and T1/2 in each one of the evaluations (T0, T5 or T30 days
after hepatectomy) as showed graphically. Time made no differences on HEF and Tmax; however, it had a significant statistical effect on T1/2 (P value
<0.001), which is visible graphically, in individuals submitted to minor hepatic resection (MIHR) (P < 0.040), as well as those who underwent major hepatic
resection (MAHR) (P < 0.035). (b) 99mTc-mebrofenin scintigraphic images obtained on a patient with colorectal liver metastases submitted to a major
hepatic resection (MAHR) 1 day before hepatectomy (T0), 5 days (T5) and 30 days after hepatectomy (T30). (c) 99mTc-mebrofenin scintigraphic images
obtained on a patient with colorectal liver metastases submitted to a minor hepatic resection (MIHR) 1 day before hepatectomy (T0), 5 days (T5) and 30
days after hepatectomy (T30).
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How could the new knowledge be applied in clinical practice?
The surprising replicative capacity of human hepatocytes has a
very important clinical significance as it has allowed us to address
the second question – the clinical applicability in real life of such
observation. To begin with, the implications of the observed results
can greatly influence the ongoing oncological practices of adjuvant
chemotherapy, possibly resulting in treatments administered much
earlier after surgical resection than the 3-week interval currently
applied by most oncologists. Similarly, the same applies to liver
resection following portal embolization. With a regeneration taking
place in the first 5 days, the planned liver resection can be performed
much earlier also. Furthermore, several conditions can influence
liver regeneration, including the extent of resection, diabetes and the
presence of underlying liver disease.25,26 In case of liver transplan-
tation, the duration of the cold ischemic period and the presence of
organ rejection are additional risk factors. The HEF calculated with
99mTc-mebrofenin can give a reliable assessment of liver function
during regeneration, and is therefore important after transplantation
or partial hepatectomy.
Conclusions
During the last few years, there have been major advances in under-
standing the mechanisms of liver regeneration. These advances
derive, to a great extent, from the studies of liver regeneration
conducted in animal models, as the results shown by us concerning
the positive correlation between HEF kinetics and LW/AW ratio
after hepatectomy, or the positive correlation between hepatocyte
proliferation evaluated by BrdU staining and HEF after partial
hepatectomy.
In parallel with the experimental work, human liver transplanta-
tion, such as cadaveric split grafts and living donors, continues to
increase, stimulating hepatologists and surgeons to learn more about
the mechanisms that regulate and promote regeneration. Our data
based on animal and clinical results support the view that human
liver regeneration is early, fast, non-anatomical and functionally
complete 5 days after hepatectomy. The findings have an important
clinical impact as they can lead to a strategy change of the
oncological therapeutic approaches like the early start of adjuvant
chemotherapy after hepatectomy.
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